Genetic Research of Monogenic Obesity in a Pediatric Cohort With Severe and Early Onset Obesity

计划入组 100 人 · 首次发布于 2022 年 5 月 5 日

Genetic Research of Monogenic Obesity in a Pediatric Cohort With Severe and Early Onset Obesity (GENOBE)

计划入组 200 人 · 首次发布于 2023 年 11 月 2 日

A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesity

计划入组 175 人 · 首次发布于 2024 年 4 月 23 日

Obesity therapeutic

Obesity exosome

Obesity(Abalone)

Zealand Pharma A/S

Denmark

Alturas Minerals Corp

United States

Novo Nordisk A/S

Denmark

Semaglutide Shows Potential for Nerve Regeneration in Children with MC4R-Related Obesity

Novo Nordisk's Cagrilintide/Semaglutide Combo Shows Superior Weight Loss in Phase III Trial

Rhythm Pharmaceuticals Appoints Kim Popovits to Board of Directors as Ed Mathers Departs